Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Delayed Price · USD
0.762
0.002 (0.21%)
At close: May 25, 2022 4:00 PM
0.760
-0.002 (-0.262%)
After-hours:May 25, 2022 5:25 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|
Selling, General & Admin | 23.06 | 24.03 | 20.05 | 16.02 | 9.62 | 5.14 |
Research & Development | 38.39 | 67.31 | 70.96 | 58.91 | 37.37 | 13.71 |
Other Operating Expenses | 0 | 2.63 | 0 | 0 | 0 | 0 |
Operating Expenses | 61.45 | 93.96 | 91 | 74.92 | 46.99 | 18.84 |
Operating Income | -61.45 | -93.96 | -91 | -74.92 | -46.99 | -18.84 |
Interest Expense / Income | 3.18 | 1.29 | 0 | 0 | 0 | 2.18 |
Other Expense / Income | -3.9 | -1.41 | -8.83 | 1.48 | -2.33 | 9.38 |
Pretax Income | -60.73 | -93.84 | -82.18 | -76.4 | -44.66 | -30.4 |
Net Income | -60.73 | -93.84 | -82.18 | -76.4 | -44.66 | -30.4 |
Net Income Common | -60.73 | -93.84 | -82.18 | -76.4 | -44.66 | -30.4 |
Shares Outstanding (Basic) | 56 | 51 | 44 | 28 | 3 | 3 |
Shares Outstanding (Diluted) | 56 | 51 | 44 | 28 | 3 | 3 |
Shares Change | 9.73% | 16.60% | 54.32% | 784.12% | 20.08% | - |
EPS (Basic) | -1.09 | -1.84 | -1.88 | -2.70 | -13.97 | -11.42 |
EPS (Diluted) | -1.09 | -1.84 | -1.88 | -2.70 | -13.97 | -11.42 |
Free Cash Flow Per Share | -0.81 | -1.55 | -1.70 | -2.05 | -12.52 | -7.00 |
EBITDA | -54.67 | -89.1 | -79.51 | -74.22 | -43.35 | -28.07 |
EBIT | -57.55 | -92.55 | -82.18 | -76.4 | -44.66 | -28.22 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).